share_log

Summit Healthcare Acquisition (SMIH) and The Competition Critical Analysis

Summit Healthcare Acquisition (SMIH) and The Competition Critical Analysis

峰會醫療收購 (SMIH) 與競爭批判性分析
Financial News Live ·  2022/12/21 02:42

Summit Healthcare Acquisition (NASDAQ:SMIH – Get Rating) is one of 710 publicly-traded companies in the "Holding & other investment offices" industry, but how does it contrast to its competitors? We will compare Summit Healthcare Acquisition to similar businesses based on the strength of its valuation, profitability, institutional ownership, earnings, risk, analyst recommendations and dividends.

峰會醫療收購(NASDAQ:SMIH — 獲得評級)是「控股及其他投資辦公室」行業中 710 家上市公司之一,但它與競爭對手的對比如何?我們將根據其估值、盈利能力、機構所有權、收益、風險、分析師建議和股息的實力,將 Summit Healthcare 收購與同類企業進行比較。

Earnings and Valuation

收益及估值

This table compares Summit Healthcare Acquisition and its competitors gross revenue, earnings per share and valuation.

此表格比較峰會醫療收購及其競爭對手的總收入、每股盈利和估值。

Get
取得
Summit Healthcare Acquisition
峰會醫療收購
alerts:
警報:
Gross Revenue Net Income Price/Earnings Ratio
Summit Healthcare Acquisition N/A -$550,000.00 12.59
Summit Healthcare Acquisition Competitors $1.72 billion $88.36 million 23.10
總收入 淨收入 市盈比率
峰會醫療收購 N/A -$550,000.00 12.59
峰會醫療收購競爭者 十二億七千萬元 八千八百三十六萬元 23.10

Summit Healthcare Acquisition's competitors have higher revenue and earnings than Summit Healthcare Acquisition. Summit Healthcare Acquisition is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

峰會醫療收購的競爭對手擁有更高的收入和收益比峰會醫療收購。Summit Healthcare 收購以低於競爭對手的價格與收益比率進行交易,這表明它目前比其他行業中的公司更經濟實惠。

Volatility and Risk

波動性和風險

Summit Healthcare Acquisition has a beta of 0.01, meaning that its share price is 99% less volatile than the S&P 500. Comparatively, Summit Healthcare Acquisition's competitors have a beta of 0.05, meaning that their average share price is 95% less volatile than the S&P 500.
峰會醫療保健收購的測試版為 0.01,這意味著其股價的波動性比標普 500 低 99%。相比之下,峰會醫療保健收購的競爭對手具有 0.05 的測試版,這意味著他們的平均股價比標普 500 少 95% 的波動性。

Profitability

盈利

This table compares Summit Healthcare Acquisition and its competitors' net margins, return on equity and return on assets.

本表比較峰峰醫療收購及其競爭對手的淨利潤率、權益回報率及資產回報率。

Net Margins Return on Equity Return on Assets
Summit Healthcare Acquisition N/A 46.53% 8.78%
Summit Healthcare Acquisition Competitors 11.67% -68.35% 2.51%
淨利潤 權益回報率 資產回報率
峰會醫療收購 N/A 46.53% 8.78%
峰會醫療收購競爭者 11.67% -68.35% 2.51%

Analyst Recommendations

分析師推薦

This is a summary of recent ratings and target prices for Summit Healthcare Acquisition and its competitors, as provided by MarketBeat.com.

這是由 MarketBeat.com 提供的峰頂醫療收購及其競爭對手的最新評分和目標價格的摘要。

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Summit Healthcare Acquisition 0 0 0 0 N/A
Summit Healthcare Acquisition Competitors 113 593 889 18 2.50
銷售評級 保留評分 購買評級 強大的買入評級 評級分數
峰會醫療收購 0 0 0 0 N/A
峰會醫療收購競爭者 113 593 889 18 2.50

As a group, "Holding & other investment offices" companies have a potential upside of 69.95%. Given Summit Healthcare Acquisition's competitors higher possible upside, analysts plainly believe Summit Healthcare Acquisition has less favorable growth aspects than its competitors.

作為一個集團,「控股及其他投資辦事處」公司的潛在上升空間為 69.95%。鑑於 Summit Healthcare 收購的競爭對手可能具有較高的上行空間,分析師清楚地認為峰會醫療收購比競爭對手具有較不利的增長

Institutional and Insider Ownership

機構和內幕所有權

64.3% of shares of all "Holding & other investment offices" companies are held by institutional investors. 17.6% of shares of all "Holding & other investment offices" companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

所有「控股及其他投資辦事處」公司的 64.3% 股份均由機構投資者持有。所有「控股及其他投資辦事處」公司的 17.6% 股份均由內幕人士持有。強大的機構所有權表明,捐贈基金,大型資金經理和對沖基金認為公司長期的表現將優於市場。

Summary

摘要

Summit Healthcare Acquisition competitors beat Summit Healthcare Acquisition on 8 of the 10 factors compared.

峰會醫療收購競爭對手在 10 個因素中的 8 個因素中擊敗了 Summit 醫療收購。

Summit Healthcare Acquisition Company Profile

峰頂醫療收購公司簡介

(Get Rating)

(取得評分)

Summit Healthcare Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Central, Hong Kong.

峰頂醫療收購公司沒有重大業務。它打算與一個或多個企業或實體實施合併,股票交換,資產收購,股票購買,重組或類似的業務組合。該公司於 2020 年註冊成立,總部位於香港中環。

Receive News & Ratings for Summit Healthcare Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Summit Healthcare Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.

每日接收峰會醫療收購的最新消息和評分 -在下面輸入您的電子郵件地址,以通過 MarketBeat.com 的免費每日電子郵件通訊接收 Summit 醫療保健收購和相關公司的最新新聞和分析師評級的簡要每日摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論